Session » Spondyloarthropathies and Psoriatic Arthritis II - Novel Treatments Psoriatic Arthritis
-
Abstract Number: 955
Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pharmacodynamic Results of a Phase 3, Randomized, Controlled Trial